6 quiz questions available for this topicTake Quiz

Contraception - natural family planning

SNOMED: 718701005697 wordsUpdated 03/03/2026
💡

Exam Tips

  • In OSCE counselling, explicitly state that fertility awareness methods and LAM do not protect against STIs; add condom advice where relevant.
  • A sustained basal temperature rise confirms ovulation retrospectively, so it is better for identifying the end of the fertile window than predicting its start.
  • LAM is only reliable when all 3 criteria are present: <6 months postpartum, fully/near-fully breastfeeding, and amenorrhoea.
  • Withdrawal is a natural method but has poor contraceptive reliability and should not be advised as the sole strategy.
  • If UPSI occurs during a potentially fertile period, discuss emergency contraception immediately (oral EC or copper IUD).
  • See Figure from menstrual physiology texts showing hormone profile, cervical mucus changes, and biphasic basal body temperature across the cycle.

Definition

Natural family planning is a group of contraceptive approaches in which a couple tracks biological fertility markers to estimate fertile days and then avoids vaginal intercourse (or uses a barrier method) during that window. In UK practice, this includes fertility awareness methods and the lactational amenorrhoea method, and effectiveness depends heavily on correct teaching, consistent daily monitoring, and cycle regularity.

Pathophysiology

Fertility awareness methods rely on cyclical ovarian hormone changes: rising oestrogen before ovulation causes clearer, wetter cervical mucus and cervical softening/opening, while post-ovulatory progesterone causes a sustained basal body temperature rise that confirms ovulation retrospectively. The fertile window reflects sperm survival in the genital tract (up to about 7 days) plus ovum viability (about 24 hours), so conception risk is highest in the days before ovulation and shortly after. Lactational amenorrhoea works through frequent suckling-induced prolactin elevation, which suppresses hypothalamic GnRH pulsatility, reducing LH/FSH release and inhibiting ovulation, but this suppression weakens as feeds reduce or menses return.

Risk Factors

  • Irregular menstrual cycles (harder to predict fertile window accurately)
  • Inconsistent or incorrect charting of fertility indicators
  • Limited access to trained fertility-awareness instruction
  • Postpartum transition with changing ovulatory patterns
  • Use of fertility signs alone in isolation (for example cervix-only method)
  • Reliance on withdrawal as a sole method
  • Intercurrent illness, poor sleep, alcohol, or shift work affecting basal temperature interpretation
  • Use in people at high risk of sexually transmitted infection (no STI protection)

Clinical Features

Symptoms

  • Cyclical change in vaginal secretions from dry/sticky to wetter, clear, slippery mucus before ovulation
  • Recognition of potentially fertile days based on cycle records
  • Postpartum amenorrhoea during exclusive breastfeeding (LAM context)
  • Anxiety about method failure after unprotected intercourse in predicted fertile period

Signs

  • Biphasic basal body temperature chart with a small sustained rise after ovulation (typically for at least 3 days)
  • Cervix becoming higher, softer, and more open around ovulation, then returning low/firm/closed after ovulation
  • Menstrual chart patterns showing cycle-length variability that may reduce reliability

Investigations

Urine pregnancy test:Negative when contraception has been effective; positive if method failure and conception has occurred
Structured fertility chart review (BBT, mucus, cycle days):Identifies likely fertile interval and common user errors (missed recordings, misread mucus/temperature trends)
If amenorrhoea persists unexpectedly: endocrine work-up (for example TSH, prolactin) guided by history:Usually normal in physiological lactational amenorrhoea; abnormal results suggest alternative causes

Management

Lifestyle Modifications

  • Provide UK contraceptive counselling on realistic failure rates (perfect vs typical use) and discuss whether reliability is acceptable for the individual/couple
  • Teach a validated fertility-awareness approach (often combining markers rather than a single marker) and advise daily recording
  • During fertile days, avoid vaginal intercourse or use condoms correctly and consistently if acceptable
  • For LAM, explain strict criteria for effectiveness: baby <6 months, exclusive/near-exclusive breastfeeding, and no return of menses
  • Advise that natural methods do not protect against STIs; recommend condoms when STI risk exists
  • Escalate to emergency contraception promptly if unprotected intercourse occurs in a potentially fertile interval

Pharmacological Treatment

Emergency hormonal contraception (if natural method failure or unprotected sex)

  • Levonorgestrel 1.5 mg orally as a single dose (as soon as possible, licensed up to 72 hours after UPSI)
  • Ulipristal acetate 30 mg orally as a single dose (up to 120 hours after UPSI)

Check interactions (especially enzyme inducers), BMI/weight considerations, timing since intercourse, and breastfeeding advice. After ulipristal, wait 5 days before starting progestogen-containing contraception; if breastfeeding, express and discard milk for 1 week after ulipristal. Levonorgestrel is generally preferred in breastfeeding.

Surgical / Interventional

  • Copper intrauterine device insertion for emergency contraception (most effective EC; can be inserted up to 5 days after earliest likely ovulation, or within 120 hours of UPSI depending on timing) and can then provide ongoing contraception

Complications

  • Unintended pregnancy (including delayed recognition in women with irregular bleeding patterns)
  • Higher failure risk with typical use compared with long-acting reversible contraception
  • Potential relationship strain or reduced sexual spontaneity due to abstinence periods
  • No STI protection unless condoms are used

Prognosis

Outcomes are highly user-dependent: with high-quality teaching and meticulous adherence, effectiveness can be acceptable for motivated couples, but typical-use failure is substantially higher than with LARC methods. LAM is effective short-term only when strict criteria are met and protection falls once feeding frequency drops, menses returns, or 6 months postpartum is reached.

Sources & References

NICE Guidelines(1)

Test Your Knowledge

6 quiz questions available for this topic

Start Quiz